Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation-Reference-Cited by-同舟云学术

Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation

Published:2004-10 Issue:10 Volume:80 Page:719-727
ISSN:0955-3002
Container-title:International Journal of Radiation Biology
language:en
Short-container-title:International Journal of Radiation Biology

Author:

Hessel F.,Krause M.,Helm A.,Petersen C.,Grenman R.,Thames H. D.,Baumann M.

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

http://www.tandfonline.com/doi/pdf/10.1080/095530003400017812

Reference20 articles.

1. Response of Human Squamous Cell Carcinoma Xenografts of Different Sizes to Irradiation: Relationship of Clonogenic Cells, Cellular Radiation Sensitivity in Vivo, and Tumor Rescuing Units

2. Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice

3. Impact of overall treatment time on local control of slow growing human GL squamous cell carcinoma in nude mice treated by fractionated irradiation

4. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

5. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical In Vivo Evaluation of Novel Radiosensitizers by Local Tumor Control Experiments;Cancer Drug Discovery and Development;2020

2. Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts;Radiation Oncology;2014-12

3. GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: Subgroup analysis of the prospective randomized CHARTWEL trial;Radiotherapy and Oncology;2013-03

4. Isolation and genomic characterization of stem cells in head and neck cancer;Head & Neck;2012-10-29

5. Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo;Radiotherapy and Oncology;2012-03